SUN VALLEY, Calif., Aug. 27 /PRNewswire-FirstCall/ -- XTend Medical Corporation , a company that delivers cutting-edge telemedicine solutions to the healthcare industry, has announced they have begun a Remote Patient Monitoring Program through the University of Ulster, U.K., with Dr. Kevin Curran heading up the program.
In addition, the company feels the current share price of their stock is not a true reflection of the value of the company’s current business state.
The company released the following statement: “We’re pleased to announce the company has begun a program in the U.K. to monitor patients remotely managing their diabetes and blood pressure. This program will be managed by Dr. Kevin Curran who states that the main focus of the program is to show how technology can assist in monitoring patients from their home in modern life with the main emphasis being to reduce costs for the healthcare systems worldwide and improve the care delivered to patients. Our program is designed to assist doctors in helping patients to control diabetes through the up-to- the-minute online reports of their insulin levels.
The company further announced that the current share price is not indicative of the true value and potential of the company. This program, along with the others that are set to begin soon, have the potential to bring in excess of $100 million dollars for the length of these contracts. This makes no sense to us how the share price declines while the business is poised to be a force in the very near future. Management’s confidence remains high and feels the future of this company remains bright.”
To find out more about Ulster University, please visit their site at http://www.ulster.ac.uk
For any healthcare agency or physician group that would like to find out more about how XTend can assist in your management of diabetic patients, please visit the company website at http://www.xtendmedical.com or email us at info@xtendmedical.com
About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at http://www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
CONTACT: Investor Relations, FutureTechIR, +1-817-812-2105, for XTend
Medical Corporation
Web site: http://www.xtendmedical.com/
http://www.ulster.ac.uk/
